Anticholinergic Adverse Reaction
7
1
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis
NUDGE-EHR Replication Trial at Mass General Brigham
Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults
Pharmacist Led Intervention to Improve Medication Use in Older In-patients Living With Frailty: the Drug Burden Index
The Effects Of Anticholinergic Burden On Daily Living Activities In Elderly Patients
Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia:
Intervention to REduce anticholinerGic burdEN in oldER pATiEnts (REGENERATE) Aged 65 Years and Older